Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04971967
Other study ID # 19-0496
Secondary ID R34MH119963
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2021
Est. completion date September 30, 2022

Study information

Verified date September 2022
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Individuals will participate in a pilot randomized controlled trial (RCT) that implements and evaluates the feasibility, acceptability, and effectiveness of crowdsourced partner services (PS) or conventional PS among Chinese men who have sex with men (MSM) living with HIV. The pilot RCT will include 120 newly identified MSM HIV cases who were born biologically male, aged 18 years old or older, newly identified as HIV positive, had oral or anal sex with a man, had at least one sexual partner in the previous 6 months and live in Guangzhou. Participants will undergo a series of computer-based interviews (baseline and 2 months after enrollment) and will be randomly assigned into two groups in 2:1 ratio (intervention: control) and receive crowdsourced PS and conventional PS, respectively.


Description:

This is a pilot RCT, and the primary outcomes of this study are: 1) to test the feasibility and acceptability of the crowdsourced intervention, and 2) to pilot the preliminary impact of crowdsourced PS intervention in promoting HIV testing among partners of the newly identified HIV cases. In addition, this pilot RCT aimed to collect preliminary data for the designing of a full RCT, which aimed to measure the efficacy of the crowdsourced PS intervention in promoting PS. Thus, the sample size of this study is not designed and will be not powered enough to test the difference between the two arms. However, with a sample size of 120 (80 for intervention arm and 40 for the control arm, respectively), this pilot study would be able to observe the differences between the two arms and collect preliminary data for adequate sample size calculation of a full RCT. With a sample size of 120 (ratio of 2:1), alpha=0.05, power=0.80, and the partner return rate in the conventional PS arm is 30% (around 31% in 2016 in Guangzhou), the minimal detectable effect size would be 26.7% for this pilot study. Data analyses: For the primary outcomes of feasibility and acceptability of the intervention: this will be analyzed through descriptive analysis to assess the feedback on the feasibility and acceptability of the crowdsourced PS intervention at baseline and the follow-up survey. For the primary outcome of the proportion of partners returning for HIV testing within 2 months of the index participant's enrolment in the study, log-binomial regression (generalized linear model with binomial distribution and log link) will be used to calculate 95% confidence intervals for the proportion of notifiable partners visiting by arm. Risk differences and risk ratios will also be calculated in these models. As this study is a pilot RCT, adjustment for covariates is not necessary and will not be conducted in the primary analysis. In secondary analyses, pre-specified potential confounding variables will be adjusted that might bias the estimate if not accounted for (e.g. index age, index marital status). If a partner reports more than one index referred him, he will be counted as a returning partner for each identified index. Subgroup analyses will be performed by partner sex, partner type (e.g. main male partner vs. casual male partner) and sexual orientation. Time to presentation will also be assessed among all notifiable partners using Cox proportional hazards with a robust variance estimator. In the time-to-event analyses, censoring will occur at the end of 2-months. Note that for the primary outcome, the assumption is that any partner without an identifiable record at the community center or in the centralized electronic medical record (EMR) did not present for HIV testing. Therefore, this study assumes no missing outcome data. Sensitivity analyses will be conducted using alternative definitions of presentation for testing, including using the self-reported data from index cases and partners. For count variables expressed as the mean number of partners, the investigators will use either Poisson regression or negative binomial regression if overdispersion is identified.


Recruitment information / eligibility

Status Completed
Enrollment 121
Est. completion date September 30, 2022
Est. primary completion date August 15, 2022
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - born biologically male, - aged 18 years old or older, - newly identified as HIV positive, - had oral or anal sex with a man, - had at least one sexual partner in the previous 6 months - live in Guangzhou Exclusion Criteria: - Not meet inclusion criteria - Not given informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Crowdsourced partner services intervention
The intervention includes the provision of provider referral and dual referral services, crowdsourced materials such as postcards and an HTML aiming to promote PS, as well as free take-home HIV self-testing kits.

Locations

Country Name City State
China Guangzhou Center for Diseases Control and Prevention Guangzhou Guangdong

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of MSM Index Cases That Respond to the Follow-up Survey at 3 Months After Enrollment Intervention feasibility, measured by the percentage of MSM index cases that respond to the follow-up survey 3 months after enrollment 3 months post enrollment
Primary Acceptability Degree of the Intervention Using an Acceptability Questionnaire Intervention acceptability, measured by the mean score of an acceptability questionnaire among index patients in the intervention group at 3-month follow-up. The questionnaire asks index patients about their responses to statements regarding the acceptability of the crowdsourced intervention materials, and is rated on a 1-5 scale with mean scores ranging between 1 and 5, where 1 means 'strongly disagree' and 5 means 'strongly agree'. Higher mean scores mean higher acceptability. 3 months post enrollment
Primary Percentage of Partners Who Perform HIV-testing Within 3 Months of the Index Patient's Enrollment The preliminary impact of the intervention, measured by the percentage of partners who perform HIV-testing within 3 months of the index patient's enrollment. Partner HIV testing is self-reported by the index, and verified by the partners uploading testing results. 3 months post enrollment
Secondary Percentage of Partners Who Were Notified Within 3 Months of the Index's Enrollment The percentage of partners who were notified by their indexes within 3 months of the index's enrollment 3 months post enrollment
Secondary Mean Number of Partners Tested Per Index The mean number of sexual partners tested per index followed for the last 3 months. 3 months post enrollment
Secondary Percentage of Partners Who Have Positive HIV Tests Among All Tested Partners The percentage of partners tested as HIV positive among partners who performed HIV-testing in the last 3 months. 3 months post enrollment
Secondary Mean Number of Case-finding Per Index The mean number of case-finding (i.e., partners tested positive) per index within 3 months post index enrollment 3 months post enrollment
Secondary Percentage of Casual Male Partners Getting HIV Testing The percentage of partners getting HIV testing who are not spouses or regular male partners 3 months post enrollment
Secondary Percentage of Presenting Partners Reporting Condom Use During the Last Anal Intercourse The percentage of presenting partners who completed the partner survey and reported condom use during the last anal intercourse 3 months post enrollment
See also
  Status Clinical Trial Phase
Completed NCT00207493 - The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services. Phase 1/Phase 2
Completed NCT00207571 - Partner Notification Intervention for STD Clinics. Phase 1/Phase 2